osudhkosh
New

Generic

Metformin Hydrochloride + Sitagliptin

52 brands available in the market

At a glance

Metformin Hydrochloride + Sitagliptin is a combination medicine that controls high blood sugar levels in type 2 diabetes mellitus. Metformin reduces glucose production and absorption, and Sitagliptin is a DPP-4 inhibitor that increases incretin hormone activity.

Description

Metformin is a biguanide that decreases hepatic glucose production, intestinal glucose absorption, and improves insulin sensitivity by increasing peripheral glucose uptake. Sitagliptin is a DPP-4 inhibitor that slows the inactivation of incretin hormones (GLP-1 and GIP), increasing insulin release from pancreatic beta cells and decreasing glucagon secretion from alpha cells.

Indications
  • Type 2 diabetes mellitus - as an adjunct to diet and exercise to improve glycemic control
Pharmacological class

Biguanide + DPP-4 Inhibitor

Pharmacology

Metformin reduces glucose production and absorption; Sitagliptin inhibits DPP-4 to increase incretin hormone levels, which stimulates glucose-dependent insulin release and reduces glucagon secretion.

Mechanism of action

Controls blood sugar by reducing glucose production and absorption and increasing incretin activity.

Dosage

Immediate Release (Adult):

  • Not on metformin: 50/500 mg twice daily
  • On metformin: Sitagliptin 50 mg twice daily + current metformin dose
  • Maximum: Sitagliptin 100 mg + Metformin 2000 mg/day

Extended Release (Adult):

  • Initial: Sitagliptin 50/100 mg + Metformin ER 500/1000 mg once daily (evening)
  • Maximum: Sitagliptin 100 mg + Metformin ER 2000 mg/day
Administration
  • Swallow tablet whole; do not chew, crush or break
  • Take with food (to reduce stomach upset)
  • Take at the same time each day
Missed dose

If you miss a dose, take it as soon as you remember; skip if it's almost time for next dose; do not double the dose.

Drug interactions
  • Additive effect with sulfonylureas (hypoglycemia risk)
  • Thiazide diuretics, corticosteroids, OCs may worsen glycemic control
  • ACE inhibitors may reduce fasting blood glucose
  • Cimetidine may increase serum levels
  • Increased risk of lactic acidosis with iodinated contrast agents (potentially fatal)
Food interactions

Alcohol consumption with Metformin + Sitagliptin is unsafe.

Contraindications
  • Renal dysfunction (males Cr >1.5 mg/dL, females >1.4 mg/dL)
  • Metabolic acidosis (including diabetic ketoacidosis)
  • History of serious hypersensitivity to sitagliptin or metformin
Side effects

Common Side Effects (≥5%):

  • Diarrhea
  • Upper respiratory tract infection
  • Headache
  • Hypoglycemia (with sulfonylurea or insulin)
  • Nausea, vomiting, upset stomach
Use in pregnancy

Use in Pregnancy: Metformin + Sitagliptin is generally considered safe during pregnancy (Category B); animal studies have shown low or no adverse effects.

Pregnancy Category: B — always consult a doctor before taking during pregnancy.

Use in lactation

Use in Lactation: Metformin + Sitagliptin is probably safe during breastfeeding; limited human data suggests no significant risk to the baby.

Precautions & warnings
  • Inform doctor if symptoms of lactic acidosis occur (deep/rapid breathing, persistent nausea, vomiting, abdominal pain)
  • Monitor blood sugar regularly to avoid hypoglycemia
  • Avoid alcohol (risk of lactic acidosis)
  • Temporarily stop before major surgery or contrast dye procedures
  • Caution in history of pancreatitis
Pediatric use

Safety and efficacy not established in children under 18 years.

Geriatric use

Elderly require dose adjustment due to potential decreased renal function; monitor renal function regularly.

Renal / hepatic impairment

Renal Impairment: eGFR <30: contraindicated; eGFR 30-45: not recommended to initiate; discontinue if eGFR falls below 30; monitor renal function regularly.

Hepatic Impairment: Probably safe in liver disease; dose adjustment may not be needed.

Overdose effects

Overdose may cause lactic acidosis; sitagliptin is modestly dialyzable; metformin is dialyzable.

Therapeutic class

Combination Oral Hypoglycemic Preparations

Storage conditions

Store below 25°C in a dry place, away from light; keep out of reach of children.

Chemical structure

Metformin Hydrochloride + Sitagliptin

Common questions

What does this combination do?
It is used to control blood sugar in type 2 diabetes.
How to use it?
Take tablets twice daily or once daily with food.
What are the side effects?
Diarrhea, nausea, headache, hypoglycemia, etc. may occur.
⚠️ This information is for educational purposes only — not a substitute for medical advice. Consult a registered physician before taking any medicine.